BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

829 related articles for article (PubMed ID: 29267140)

  • 1. Human Wharton's Jelly-Derived Stem Cells Display a Distinct Immunomodulatory and Proregenerative Transcriptional Signature Compared to Bone Marrow-Derived Stem Cells.
    Donders R; Bogie JFJ; Ravanidis S; Gervois P; Vanheusden M; Marée R; Schrynemackers M; Smeets HJM; Pinxteren J; Gijbels K; Walbers S; Mays RW; Deans R; Van Den Bosch L; Stinissen P; Lambrichts I; Gyselaers W; Hellings N
    Stem Cells Dev; 2018 Jan; 27(2):65-84. PubMed ID: 29267140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of human mesenchymal stem cells from fetal-bone marrow, adipose tissue, and Warton's jelly as sources of cell immunomodulatory therapy.
    Wang Q; Yang Q; Wang Z; Tong H; Ma L; Zhang Y; Shan F; Meng Y; Yuan Z
    Hum Vaccin Immunother; 2016; 12(1):85-96. PubMed ID: 26186552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.
    Batsali AK; Pontikoglou C; Koutroulakis D; Pavlaki KI; Damianaki A; Mavroudi I; Alpantaki K; Kouvidi E; Kontakis G; Papadaki HA
    Stem Cell Res Ther; 2017 Apr; 8(1):102. PubMed ID: 28446235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Wharton's Jelly-Derived Stem Cells Display Immunomodulatory Properties and Transiently Improve Rat Experimental Autoimmune Encephalomyelitis.
    Donders R; Vanheusden M; Bogie JF; Ravanidis S; Thewissen K; Stinissen P; Gyselaers W; Hendriks JJ; Hellings N
    Cell Transplant; 2015; 24(10):2077-98. PubMed ID: 25310756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term expansion and pluripotent marker array analysis of Wharton's jelly-derived mesenchymal stem cells.
    Nekanti U; Rao VB; Bahirvani AG; Jan M; Totey S; Ta M
    Stem Cells Dev; 2010 Jan; 19(1):117-30. PubMed ID: 19619003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional module analysis reveals differential osteogenic and stemness potentials in human mesenchymal stem cells from bone marrow and Wharton's jelly of umbilical cord.
    Hsieh JY; Fu YS; Chang SJ; Tsuang YH; Wang HW
    Stem Cells Dev; 2010 Dec; 19(12):1895-910. PubMed ID: 20367285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuronal plasticity of human Wharton's jelly mesenchymal stromal cells to the dopaminergic cell type compared with human bone marrow mesenchymal stromal cells.
    Datta I; Mishra S; Mohanty L; Pulikkot S; Joshi PG
    Cytotherapy; 2011 Sep; 13(8):918-32. PubMed ID: 21696238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced neuro-therapeutic potential of Wharton's Jelly-derived mesenchymal stem cells in comparison with bone marrow mesenchymal stem cells culture.
    Drela K; Lech W; Figiel-Dabrowska A; Zychowicz M; Mikula M; Sarnowska A; Domanska-Janik K
    Cytotherapy; 2016 Apr; 18(4):497-509. PubMed ID: 26971678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of chemokine and receptor gene expression between Wharton's jelly and bone marrow-derived mesenchymal stromal cells.
    Balasubramanian S; Venugopal P; Sundarraj S; Zakaria Z; Majumdar AS; Ta M
    Cytotherapy; 2012 Jan; 14(1):26-33. PubMed ID: 22091833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New emerging potentials for human Wharton's jelly mesenchymal stem cells: immunological features and hepatocyte-like differentiative capacity.
    Anzalone R; Lo Iacono M; Corrao S; Magno F; Loria T; Cappello F; Zummo G; Farina F; La Rocca G
    Stem Cells Dev; 2010 Apr; 19(4):423-38. PubMed ID: 19958166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stage-specific embryonic antigen 4 in Wharton's jelly-derived mesenchymal stem cells is not a marker for proliferation and multipotency.
    He H; Nagamura-Inoue T; Tsunoda H; Yuzawa M; Yamamoto Y; Yorozu P; Agata H; Tojo A
    Tissue Eng Part A; 2014 Apr; 20(7-8):1314-24. PubMed ID: 24279891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct Comparison of Wharton's Jelly and Bone Marrow-Derived Mesenchymal Stromal Cells to Enhance Engraftment of Cord Blood CD34(+) Transplants.
    van der Garde M; van Pel M; Millán Rivero JE; de Graaf-Dijkstra A; Slot MC; Kleinveld Y; Watt SM; Roelofs H; Zwaginga JJ
    Stem Cells Dev; 2015 Nov; 24(22):2649-59. PubMed ID: 26414086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chondrogenic induction of mesenchymal stromal/stem cells from Wharton's jelly embedded in alginate hydrogel and without added growth factor: an alternative stem cell source for cartilage tissue engineering.
    Reppel L; Schiavi J; Charif N; Leger L; Yu H; Pinzano A; Henrionnet C; Stoltz JF; Bensoussan D; Huselstein C
    Stem Cell Res Ther; 2015 Dec; 6():260. PubMed ID: 26718750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Analyses of Immunosuppressive Characteristics of Bone-Marrow, Wharton's Jelly, and Adipose Tissue-Derived Human Mesenchymal Stem Cells.
    Karaöz E; Çetinalp Demircan P; Erman G; Güngörürler E; Eker Sarıboyacı A
    Turk J Haematol; 2017 Aug; 34(3):213-225. PubMed ID: 27610554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pluripotent gene expression in mesenchymal stem cells from human umbilical cord Wharton's jelly and their differentiation potential to neural-like cells.
    Tantrawatpan C; Manochantr S; Kheolamai P; U-Pratya Y; Supokawej A; Issaragrisil S
    J Med Assoc Thai; 2013 Sep; 96(9):1208-17. PubMed ID: 24163998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive characterization of four different populations of human mesenchymal stem cells as regards their immune properties, proliferation and differentiation.
    Li X; Bai J; Ji X; Li R; Xuan Y; Wang Y
    Int J Mol Med; 2014 Sep; 34(3):695-704. PubMed ID: 24970492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adipose-tissue-derived and Wharton's jelly-derived mesenchymal stromal cells suppress lymphocyte responses by secreting leukemia inhibitory factor.
    Najar M; Raicevic G; Boufker HI; Fayyad-Kazan H; De Bruyn C; Meuleman N; Bron D; Toungouz M; Lagneaux L
    Tissue Eng Part A; 2010 Nov; 16(11):3537-46. PubMed ID: 20597819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wharton's jelly derived mesenchymal stromal cells: Biological properties, induction of neuronal phenotype and current applications in neurodegeneration research.
    Frausin S; Viventi S; Verga Falzacappa L; Quattromani MJ; Leanza G; Tommasini A; Valencic E
    Acta Histochem; 2015; 117(4-5):329-38. PubMed ID: 25747736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulatory effects of human umbilical cord Wharton's jelly-derived mesenchymal stem cells on differentiation, maturation and endocytosis of monocyte-derived dendritic cells.
    Saeidi M; Masoud A; Shakiba Y; Hadjati J; Mohyeddin Bonab M; Nicknam MH; Latifpour M; Nikbin B
    Iran J Allergy Asthma Immunol; 2013 Mar; 12(1):37-49. PubMed ID: 23454777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteogenic commitment of Wharton's jelly mesenchymal stromal cells: mechanisms and implications for bioprocess development and clinical application.
    Cabrera-Pérez R; Monguió-Tortajada M; Gámez-Valero A; Rojas-Márquez R; Borràs FE; Roura S; Vives J
    Stem Cell Res Ther; 2019 Nov; 10(1):356. PubMed ID: 31779673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.